Insider Trading Fueled by Secret Trial Data! $65K Profits Exposed!

SEC v. Rakesh Ahuja — U.S. Securities and Exchange Commission Litigation Release No. 26567, dated June 15, 2026.

The SEC filed a settled action against Rakesh Ahuja, a former investment advisory firm employee, for insider trading. Ahuja allegedly used confidential clinical trial data and other material nonpublic information obtained during his employment to trade in a relative's brokerage account. These trades occurred on four occasions between June 2022 and July 2023, resulting in approximately $65,000 in profits. Ahuja consented to a permanent injunction, a two-year ban from the investment advisory industry, and monetary penalties.

In Plain English

Imagine you work for a company that helps people invest in drug companies. Your job is to research these companies, and you learn secret information about them, like whether a new medicine works well or not. Instead of keeping this secret, you secretly tell a family member to buy or sell stocks before everyone else finds out the news. This is like knowing a store is going to have a huge sale tomorrow and telling your friend to buy a lot of stuff today before the prices go up. The SEC found out and stopped this, making the person pay back the money they made and face other penalties.

Disclaimer: all facts are drawn from the SEC's own filings; the claims described are allegations unless and until a court rules or the parties settle, and some cases end in dismissal.

How the Alleged Scheme Worked

1. Access to Confidential Information Rakesh Ahuja worked as a senior associate at an investment advisory firm (IA Firm) that specialized in biopharmaceutical and biotechnology companies. As part of his job, he was given access to material nonpublic information, including confidential clinical trial data, from these companies during the firm's due diligence process.
2. Breach of Duty Ahuja owed a duty to his employer, IA Firm, not to misuse or disclose this confidential information. He was also bound by the firm's policies and securities laws. Despite these obligations, Ahuja allegedly decided to use the information for personal gain.
3. Trading Through a Relative Instead of trading directly, Ahuja caused a brokerage account registered in the name of one of his close relatives to execute trades. This action was intended to distance himself from the illicit trading activity.
4. Timing Trades Before Announcements Ahuja allegedly timed these trades to occur just before material announcements by the companies he was researching. This allowed the trades to capitalize on the predictable price movements that would follow public disclosure of the confidential information.
5. Multiple Instances of Trading This conduct was not a one-time event. Ahuja allegedly engaged in these unlawful trades on multiple occasions, specifically on at least four separate occasions between June 2022 and July 2023.
6. Profiting from Insider Information As a direct result of these trades based on material nonpublic information, Ahuja's relative's account allegedly realized profits totaling approximately $65,000.
7. Attempted Cover-up In January 2024, Ahuja resigned from IA Firm. During his exit, he reportedly represented on two occasions that he did not recognize a relative's name on a list compiled by FINRA, which identified individuals potentially involved in trading securities based on confidential information before public announcements.

The Enforcement Action

On June 3, 2026, the SEC filed a settled action against Rakesh Ahuja, a former investment advisory firm employee, for insider trading. Ahuja allegedly used confidential information, including clinical trial data, obtained during his employment to trade in a relative's brokerage account on four occasions between June 2022 and July 2023, generating approximately $65,000 in profits. Without admitting the allegations, Ahuja consented to a permanent injunction against violating antifraud provisions, a two-year bar from acting as or being associated with an investment adviser, broker, or dealer, and to pay disgorgement of $65,404.25, prejudgment interest of $12,289.01, and a civil penalty of $65,404.25.

Named in this action: Rakesh Ahuja.

Original SEC litigation release ↗ · Browse all cases